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Abstract
Diterpenes are a structural class of molecules that are derived from four isoprene subunits and are
widespread throughout nature. A number of neoclerodane diterpenes have been found to have
biological activity but a limited number of chemical investigations have been conducted. Recently,
the neoclerodane diterpene, salvinorin A (12) has been investigated due to its unique pharmacological
profile. This review will discuss the chemical methods used to chemically modify and synthesize
12.
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Terpenes are a wide variety of 10-carbon skeletons formed from the coupling of two isoprene
subunits.1 They are ubiquitous in nature as they are used as biosynthetic building blocks in
many living organisms including plants and animals.1 There are many different types of
terpenes and they are classified by their structure.1 Diterpenes are one class that possess a core
20-carbon skeleton and are found in many different plant families and some animals.1 They
are biosynthesized by two different pathways, the mevalonic acid pathway (MVA) or the
deoxyxylulose phosphate pathway (DOXP).2–5 Diterpenes are of interest as many have been
found to have biological activity. Some biologically active diterpenes include taxol (1), cafestol
(2) and kahweol (3) (Figure 1). Diterpenes 1–3, isolated from Taxus brevifolia6 and Coffea
arabica respectively,7,8 all display anticancer properties.
One type of structural class of diterpenes are clerodanes which are found in many different
plant families and contain four contiguous stereocenters contained in a cis or trans decalin
(4).9,10 Various clerodane diterpenes have been isolated and displayed biological activity.
These include columbin (5), isolated from the roots of Calumbae radix,11 which has cancer
chemo-preventive properties12 and clerocidin (6), isolated from Oidiodendron truncatum,13
which has shown antibiotic activity.13 Terpentecin (7), a microbial clerodane diterpene from
© 2009 Elsevier Ltd. All rights reserved.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting
proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could
affect the content, and all legal disclaimers that apply to the journal pertain.
NIH Public Access
Author Manuscript
Bioorg Med Chem Lett. Author manuscript; available in PMC 2010 November 10.
Published in final edited form as:













Streptomyces sp., has shown to be an antitumor antibiotic that targets DNA topoisomerase II.
14
Neoclerodanes are a subtype of clerodane diterpenes that share the same absolute
stereochemistry of clerodin (8).2 Neoclerodane 8, displays antifeedant properties and inhibits
insect growth.15 These attributes have also been seen in other neoclerodanes such as
ajugatansin A1 (9), and tafricanin A (10). These discoveries have implications for agriculture,
as neoclerodane diterpenes, may have potential use as environmentally benign pest deterrents.
16 One such example is callicarpenal (11), which has been shown to be a mosquito bite
detterant17,18 and a repellant of the blacklegged tick, lxodes scapularis and the lone star tick,
Amblyomma americanum.19
Despite their biological properties, few synthetic works have been published on neoclerodane
diterpenes.9,20–22 One neoclerodane diterpene that has been investigated recently is salvinorin
A (12). Neoclerodane 12 is isolated from the leaves of Salvia divinorum, and has shown to
have hallucinogenic effects.23–26 However, 12 is unlike classical hallucinogens, as it does not
interact with the 5-HT2A receptor.25,27 Rather, 12 is a selective κ opioid agonist.28 This was
the first report of a neoclerodane diterpene to be active at opioid receptors,28 thus establishing
neoclerodane diterpenes as a novel scaffold for opioid ligands.27,29 The chemical modification
of 12 has been undertaken by several groups, including our own, to explore its chemical
reactivity and to develop analogues that explore its pharmacophore at opioid receptors.30–35
Neoclerodane 12 is a highly functionalized molecule with a tricyclic core structure and seven
chiral centers. Feeding experiments with [1-13C;3,4-2H2]-1-deoxy-D-xylulose (DOX) have
shown that 12 is biosynthesized in a manner consistent with the deoxyxylulose phosphate
pathway.36 The chiral center at the C8 position of 12 has shown to readily undergo
epimerization under acidic or basic conditions (Figure 2).30–32,34,35 Epimerization at this
center has shown to have great impact on biological activity.26,34,37–39 Despite these issues,
several methods to explore the chemical reactivity of 12 have been developed.
Some of the initial chemical investigations of 12 attempted to remove the C2 acetate. Heating
of 12 with strong base leads to the formation of 13 in 69% yield.40,41 Treatment of 12 with
KOH in CH3OH leads to the oxidized products 14a and 15 in 53% and 37% yield respectively.
35 Using Ba(OH)2 in place of KOH in CH3OH gave 14b in 75% yield.34 This transformation
was also attempted using KCN in refluxing CH3OH/tetrahydrofuran.42 While this method was
able to remove the acetate, it led to epimerization at C8 as the major product with 51% yield.
Selective removal of the C2 acetate of 12 was accomplished in 77% yield using Na2CO3 in
CH3OH,30 yielding salvinorin B (16) (Figure 3). Ammonolyis of 12 using NH3 and CH3OH
at 0 ° C gave 16 in 15% yield with its C8 epimer in a 1:1 ratio.32
Several groups have explored the reactivity of the carbonyl at C1 on the A ring of 12.43,44 The
reaction of 12 with NaBH4 at 35 °C gives the corresponding C1 alcohol as a 1:1 mixture of
the α and β isomers in 40% yield.43 However, this method also causes epimerization at C8 in
40% yield.43 More recently, the reduction at C1 was improved by using an aqueous solution
of NaBH4 in tetrahydrofuran.44 This method gave primarily the α-alcohol 17 in 77% yield with
no epimerization at C8 and minimal reduction at C17.44
Conditions to selectively hydrolyze the C4 carbomethoxy group have also been identified.33,
34 Heating 12 with LiSEt in DMPU followed by treatment with Ac2O gave acid 18 and its C8
epimer in a 1.4:1 ratio with 73% overall yield.37 Alternatively, heating 12 with LiI in pyridine
also hydrolyzed the C4 ester to the acid in a reported 70% yield and avoided C2 deacetylation.
34 However, this method also caused C8 epimerization in a 1:1 ratio with 18.34
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Treatment of 12 with excess DIBAL-H in THF at −78 °C reduced the C17 lactone to give lactol
19 as a 1:1 mixture of epimers in 65% yield.37,42 The reduction appears quite selective as other
functional groups are not effected and epimerization did not occur. However, 19 is not stable
and undergoes elimination overnight.37
The reaction of 12 with NaIO4 and a catalytic amount of RuCl3•H2O in a mixture of acetonitrile/
H2O/CCl4 affords acid 20 in 93% yield.45 Hydrogenation of 12 using rhodium on carbon gave
21 as a mixture of C13 epimers along with 2246 in 59% and 28% yield respectively. If palladium
on carbon is used for the hydrogenation, hydrogenolysis (22) is favored.36,43 Bromination of
the furan at the 2-position 23a, can be achieved using N-bromosuccinamide (NBS) in
acetonitrile46 or CHCl3 40 with yields ranging from 10 – 60%.40,46 Dibromination at the 2-
and-5 positions of the furan ring 23b, can be achieved using Br2 and CH2Cl2 at −30 °C in 52%
yield.47 Treatment of 12 with Br2 and CH3OH affords dimethoxy, dihydrofuran 24 as a mixture
of isomers in 61% yield.46 Finally, photo-oxidation of 12 gave the γ-hydroxy butenolides 25
as a 1:3 mixture of isomers in 25% yield.46
While 12 is a structurally complex natural product, a variety of reactions have been identified
that have helped establish the chemical reactivity of 12, as well as prepare a wide array of
analogues of 12 to explore its structure-activity relationships.48 Along with the work conducted
to explore the chemical reactivity of 12, several groups have made attempts at the total synthesis
of 12.49–53 To date, there have been two successful syntheses of 12.51,52 These efforts provide
avenues to analogues that are difficult or unattainable by semi-synthesis.
In 2007, Evans and co-workers completed the first total synthesis of 12 in 33 steps with 4.5%
overall yield.51 Evans envisioned 12 as being derived from macrolactone 26 through a
transannular Michael reaction (Figure 4).54–56 Macrolactone 26 would then be assembled
through the coupling of vinyl iodide 27 and aldehyde 28. Ketone 29 (Scheme 1) is prepared in
70% yield from the addition of propyne to 3-furaldehyde followed by oxidation with MnO2.
Reduction of 30 with (R)-β-Methyl-oxazaborolidene gave alcohol 30 in 85% yield. Alkyne
isomerization, using KH and H2N(CH2)3NH2, followed by carboalumination and protection
of the alcohol with TES-Cl gave 27 in 68% yield. Claisen condensation57 of ethyl hydrogen
malonate and thiazolidinethione 31 gave the β-ketoester 32 in 85% yield. Selective formation
of the (Z) enol phosphate using lithium hexamethyldisilazide and ClPO(OEt)2 followed by Fe-
catalzyed cross-coupling gave olefin 33 in 92% yield. Aldol addition, alcohol protection and
acetylide addition yielded propargylyic alcohol 34 in 83% yield. Alcohol 34 was then subjected
to protection, semi-hydrogenation, dihydroxylation and finally oxidative cleavage to give
aldehyde 28 in 92% yield. The reaction of a grignard reagent derived from vinyl iodide 27 and
aldehyde 28 gave alcohol 35 in 75% yield. Silation of 35 with TBSOTf, followed by TES
deprotection using PPTS and hydrolysis using LiOH gave 36 in 93% yield. The Shiina
procedure for macrolactonization followed by desilylation and oxidation gave 26 in 95% yield.
58 Treatment of 26 with TBAF at −78 °C and warming to 5 °C triggered the transannular
cascade to give the tricyclic compound 37 as a single diastereomer in 95% yield. Enol 37 was
deoxygenated to 38 using a sequence of triflate formation, catalytic reduction and conjugate
reduction. Deprotection of 38, followed by oxidation and esterification afforded 8-epi-16 in
95% yield. Finally, epimerization of the C8 position with K2CO3 in CH3OH, followed by
acylation gave 12 in 78% yield.
In 2008, Hagiwara and co-workers also published a total synthesis of 12 in 20 steps with 0.15%
yield.52 They envisioned 12 being synthesized from the hydroxy- ketone 39 through a linear
series of functionalizations (Figure 5). Protection of the (R)- (−)-Wieland-Miescher ketone59
followed by treatment with NH4Cl in KOH and CH3OH gave the hydroxy-ketone 39 in 73%
yield (Scheme 2). A reductive alkylation of 39 gave a mixture of 40 and 41 in 21% and 51%
yield, respectively. Compound 41 was then deprotected and the resulting diketone was
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subjected to double Wittig methylenation60 with NaHMDS and Ph3PCH3Br to give ester 42
which was immediately reduced with LAH and the corresponding diols protected to afford
43 in 54% yield. Hydroboration followed by oxidation gave di-aldehyde 44 in 94% yield.
Protection of the formyl groups, deprotection of the TBS ether and subsequent oxidation gave
aldehyde 45 in 78% yield. The reaction of 3-lithiofuran with 45 gave the desired 12S
furylalcohol 46 and its 12R epimer in 66% yield and in a 2:3 ratio. Deprotection of the S isomer
of 46, followed by oxidation and esterification gave 2-desacetoxy salvinorin A 47 in 90% yield.
Treatment of 47 with NaHMDS and TES-Cl in THF at −78° gave the corresponding silyl enol
ether which was then subjected to Rubottom oxidation to yield 2-epi-1761 in 70% yield.
Inversion of the stereochemistry at C2 using Mitsunobu conditions62 followed by acylation,
gave 12 in 86% yield.
Diterpenes are a diverse class of natural products with several subtypes, including
neoclerodanes. Neoclerodane 12 serves as a useful example for the development of
methodology to modify other neoclerodane diterpenes. Modifications to the structure of 12
have aided in determining its chemical reactivity as well as provide a platform for analogue
development. Attempts to remove the C2 acetate of 12 with base leads to a mixture of products.
This reaction was later optimized using Na2CO3 and CH3OH. The C1 carbonyl of 12 can be
selectively reduced and the C4 methyl ester has been converted to the corresponding acid. The
C17 lactone may be selectively reduced using DIBAL-H. The furan ring of 12 may be reduced
or oxidatively degraded to the C13 carboxylic acid. The total synthesis of 12 has been
accomplished by two different groups and offers a strategy towards obtaining analogues of
12 that are otherwise inaccessible by semi-synthesis. Further advances in the synthesis of
neoclerodane diterpenes are likely to further develop this structural class of terpenes into useful
biological probes.
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Structures of taxol (1), cafestol (2), kahweol (3), diterpene skeleton (4), columbin (5),
clerocidin (6), terpentecin (7), neoclerodanes clerodin (8), ajugatansin A1 (9), tafricanin A1
(10), callicarpenal (11) and salvinorin A (12).
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Compounds obtained through basic hydrolysis of 12.
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Structures of selected modifications to 12.
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Retrosynthesis of 12 as proposed by Scheerer et al.50
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Retrosynthesis of 12 as proposed by Nozawa et al.51
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Synthesis of 12 by Scheerer et al.50 Reagents and conditions: (a) propyne, n-BuLi, Et2O, −78
°C; (b) (R)-β-Methyl-CBS catalyst, BH3•Me2S, −30 °C; (c):(1) KH, H2N(CH2)3NH2, 0 °C;
(2) Me3Al, Cp-2ZrCl2, I2, −45 °C; (3) TESCl, imidazole; (d) Ni-(R)-BINAP(OTf)2, 2,6-
lutidine, BF3•OEt2, HC(OMe)3; (e) HO2CCH2CO2Et, i-PrMgCl, 65 °C ; (f) LiHMDS ; ClPO
(OEt)2 ; (g) Fe(acac)3, MeMgCl, −20 °C; (h):(1) DIBAL-H, −78 °C; (2) MnO2; (3) Sn
(OTf)2, N-ethylpiperidine, chiral auxiliary, −78 °C; (i): (1) TBSOTf, 2,6-lutidine; (2)
K2CO3, CH3OH; (3) OsO4, NMO, NaIO4; (4) Zn(OTf)2, (−)-N-Methyl-ephedrine, Et3N, 4-
phenyl-1-butyne; (j):(1) BOMCl, NaHMDS, −78 °C; (2) Lindlar catalyst, H2; (3) K2OsO4,
NMO, citric acid, 50 °C, Pb(OAc)4, K2CO3; (k) 27, n-BuLi, MgBr•OEt2, CH2Cl2, −78 to 0 °
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C; (l): (1) TBSOTf, 2,6-lutidine; (2) PPTS, CH3OH; (3) LiOH, i-PrOH, H2O; (m):(1) MNBA,
DMAP, [0.0015 M]; (2) TBAF; (3) Dess-Martin periodinane; (n) TBAF, −78 to 5 °C; (o): (1)
NaH, Comins reagent; (2) Pd(OAc)2, dppf, Et3SiH; (3) L-selectride, t-BuOH, −78 to −55 °C;
(p) LiBF4, acetonitrile/H2O; (q) NaClO2, TMSCHN2; (r) K2CO3, CH3OH; (s) Ac2O, pyridine,
DMAP.
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Synthesis of 12 by Nozawa et al.51 Reagents and conditions: (a) (CH2)2(OTMS)2, Me3SiOTf,
15 Kbar, 40 °C; (b) KOH, CH3OH/H2O, 65 °C; (c) Li/NH3, THF, −78°C, alkyl iodide; (d) 3M
HCl aqueous EtOH; (e) NaHMDS, Ph3PCH3Br, THF; (f) LAH, Et2O, 0 °C; (g) TBSCl, DMAP,
Et3N, CH2Cl2 (h) NaH, MPMCl, DMF; (i)BH3, tetrahydrofuran, 3M NaOH, H2O2; (j) PDC,
AcONa, MS-4Å, CH2Cl2; (k) NaOMe, CH3OH; (l) ethylene glycol, PTSA, 40 °C; (m) TBAF,
THF; (n) PDC, AcONa, MS-4Å, CH2Cl2; (o) 3-Bromofuran, t-BuLi, THF, −78 °C; (p) PTSA,
acetone, H2O, reflux; (q) DDQ, H2O, CH2Cl2, 0 °C; (r) PDC, 2-methyl-2-butene, DMA; (s)
DCC, DMAP, CH3OH, CH2Cl2; (t) NaHMDS, TESCl, THF; (u) m-CPBA, NaHCO3, toluene,
H2O, 0 °C, AcOH; (v) PPh3, DIAD, AcOH, CH2Cl2.
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